Study on Resected Cases of Colon/Rectum Cancer in a Rural Area Adjacent to Hiroshima City
Study was made on total of 304 cases of cancer of the large intestine resected during the period of 12 years from 1978 to 1989. Colon cancer accounted for 56.8% of the total and rectal cancer 43.2%. There were no sexual differences. Those people aged 50 and older represented 86.0% of the total numbe...
Saved in:
Published in | JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE Vol. 40; no. 1; pp. 31 - 35 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English Japanese |
Published |
THE JAPANESE ASSOCIATION OF RURAL MEDICINE
1991
|
Online Access | Get full text |
Cover
Loading…
Summary: | Study was made on total of 304 cases of cancer of the large intestine resected during the period of 12 years from 1978 to 1989. Colon cancer accounted for 56.8% of the total and rectal cancer 43.2%. There were no sexual differences. Those people aged 50 and older represented 86.0% of the total number of the cases. By age group, those in their 60s topped the list with 27.3%, followed by those in 70s with 24.4%. Almost all the cases (95.1%) were of the patients who had visited the hospital, having noticed symptoms themselves. A very few cases were detected among the people without subjective symptoms when they received group medical Checkups. By region, 39.4% of the colon cancer cases were found in S, followed by A. In the cases of rectum cancer, Rb accounted for 50.7%. Of the total caces, 74.5% had cancer on the left side of the large intestine. Resection rate was 91.5%. The rate of resection leading to cure was 71.8%. Broken down by histological staging, stage I came to 11.7%; stage II, 30.9%; stage III, 21.8%; stage IV, 11.7%; stage V, 23.8%. The 5-year-survival rete averaged 57.1%. In pre-surgery tests, the positive rate of CEA was as low as 46.6%. The positive rate for early cancer was extremely low. Measurement of CEA levels as an auxiliary diagnosis, therefore, did not prove itself to be useful in searching for cancer. |
---|---|
ISSN: | 0468-2513 1349-7421 |
DOI: | 10.2185/jjrm.40.31 |